A clinical study of drug Eranda for the treatment in patients of Aamvata and Vatarakta

Phase 2/3

Not yet recruiting

• Conditions: Other articular cartilage disorders. Ayurveda Condition: AMAVATAH, vAtarakta,

• Registration Number: CTRI/2022/07/043885
• Lead Sponsor: Government Ayurvedic College

Brief Summary

In this trial we are selecting patients of Amavata and Vatarakta separately in two groups, In which we will do intervention study of study with drug Eranda mool in the form of Kwath preparation, with the Dose of 50 ml. BID. Assessment will be done on the subjective and objective parameters for both the diseases individually.

Route of administration - ORAL

Follow up - Day 15, Day30 while taking medicine and after 15 days after stopping of medicicne.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-08-07
• Study Start: 2022-11-07

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 1.Patients with written consent, 2.Having clinical features of Amavata or Vatarakta, 3.Patients fulfilling subjective and objective criteria like sandhi shool, shotha, sandhi stabhdhata etc.
• in amavata and Sandhi graha, twaka vaivrnaya, raga etc.
• in vatarakta.

Exclusion Criteria

• 1.Patients below 30 and above 70 years of age 2.
• Pregnant and lactating mothers 3.
• Patients with serious systemic illness 4.
• Patients with complications of Amavata and Vatarakta.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective Parameter- Grading will be done with signs and symptoms of both Amavata and Vatarakta respectively.	After one month intervention of Erandamool kwatha orally and 15 days after stopping of medicine
RA Factor, CRP, ESR for Amavata and Uric Acid levels for Vatarakta	After one month intervention of Erandamool kwatha orally and 15 days after stopping of medicine

Secondary Outcome Measures

Name	Time	Method
Subjective Parameter- Grading will be done with signs and symptoms of both Amavata and Vatarakta respectively.	RA Factor, CRP, ESR for Amavata and Uric Acid levels for Vatarakta.

Trial Locations

Locations (1)

Government Ayurvedic Hospital, Patiala; 🇮🇳 Patiala, PUNJAB, India

Government Ayurvedic Hospital, Patiala

🇮🇳Patiala, PUNJAB, India

Dr Anubhav

Principal investigator

9872955005

anubhav.salhotra@gmail.com